Oncodesign Precision Medicine Announces A 6 Million Euros Bank Financing From Caisse D’Épargne Bourgogne Franche Comté, Crédit Agricole De Champagne Bourgogne And Société Générale
Round Type
Funding Round
DijonBiotechnologyHealth CareInvestors
Description
Regulatory News:
Quick answer
Oncodesign Precision Medicine raised an undisclosed amount in a Funding Round round, dated October 5, 2023. Investors: P.C.G., Bpifrance, Société Générale, Crédit Agricole Champagne Bourgogne and Caisse D'épargne Bourgogne Franche Comté. Oncodesign Precision Medicine is based in Dijon, Bourgogne – Franche-Comté, France.
- How much did Oncodesign Precision Medicine raise?
- Oncodesign Precision Medicine raised an undisclosed amount in a Funding Round round on October 5, 2023.
- Who invested in Oncodesign Precision Medicine?
- P.C.G., Bpifrance, Société Générale, Crédit Agricole Champagne Bourgogne and Caisse D'épargne Bourgogne Franche Comté are named as investors in this round.
- What does Oncodesign Precision Medicine do?
- Oncodesign Precision Medicine (OPM) is a biopharmaceutical company specializing in precision medicine for the treatment of resistant and metastatic cancers.
- Where is Oncodesign Precision Medicine based and how big is it?
- Oncodesign Precision Medicine is based in Dijon, Bourgogne – Franche-Comté, France. Fundz records about 18 employees.
- Who are the decision-makers at Oncodesign Precision Medicine?
- Fundz holds 1 contact at Oncodesign Precision Medicine. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Oncodesign Precision Medicine that raised within 45 days of this round, from Fundz verified event records.
- Route 92 Medical raised $31M (Series F) on November 16, 2023.
- Greenbrook TMS raised $2.5M (Seed) on November 16, 2023.
- On Target Laboratories raised $30M (Funding Round) on November 16, 2023.
- Nature's Toolbox raised $48M (Series B) on November 16, 2023.
- Femasys raised an undisclosed amount (Corporate Round) on November 15, 2023.
- MAIA Biotechnology raised $4.9M (Seed) on November 15, 2023.
Who to call at Oncodesign Precision Medicine, and when
A new round usually means Oncodesign Precision Medicine is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Oncodesign Precision Medicine raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Oncodesign Precision Medicine, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Oncodesign Precision Medicine. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Oncodesign Precision Medicine raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Oncodesign Precision Medicine raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.